2023 - Research.com Best Female Scientist Award
2023 - Research.com Microbiology in United Kingdom Leader Award
2022 - Research.com Best Female Scientist Award
Her primary scientific interests are in Internal medicine, Immunology, Acquired immunodeficiency syndrome, Viral load and Cohort. The Internal medicine study combines topics in areas such as Gastroenterology and Surgery. Her Immunology research incorporates themes from Proportional hazards model and Confidence interval.
Her work carried out in the field of Acquired immunodeficiency syndrome brings together such families of science as Odds ratio, Epidemiology, Disease, Pediatrics and Risk factor. Her studies in Viral load integrate themes in fields like Chemotherapy, Regimen, Ritonavir, Survival analysis and Drug resistance. Her study in Cohort is interdisciplinary in nature, drawing from both Life expectancy, Gerontology and Cardiology.
The scientist’s investigation covers issues in Internal medicine, Immunology, Acquired immunodeficiency syndrome, Viral load and Cohort. Her work deals with themes such as Surgery and Oncology, which intersect with Internal medicine. Her research in Immunology focuses on subjects like Antiretroviral therapy, which are connected to Intensive care medicine.
Caroline Sabin interconnects Proportional hazards model, Epidemiology, Pediatrics and Immunodeficiency in the investigation of issues within Acquired immunodeficiency syndrome. In her study, which falls under the umbrella issue of Viral load, Nevirapine is strongly linked to Efavirenz. The study incorporates disciplines such as Incidence and Disease in addition to Cohort.
Internal medicine, Cohort, Cohort study, Acquired immunodeficiency syndrome and Viral load are her primary areas of study. Her study explores the link between Internal medicine and topics such as Oncology that cross with problems in Drug resistance. Her Cohort research includes elements of Men who have sex with men, Immunology, Hazard ratio, Prospective cohort study and Comorbidity.
Caroline Sabin works mostly in the field of Cohort study, limiting it down to topics relating to Demography and, in certain cases, Epidemiology, as a part of the same area of interest. Her studies deal with areas such as Hepatitis B and Hepatitis as well as Acquired immunodeficiency syndrome. Caroline Sabin has researched Viral load in several fields, including Young adult, Survival analysis, Pediatrics and Antiretroviral therapy.
Her primary areas of investigation include Internal medicine, Cohort, Acquired immunodeficiency syndrome, Cohort study and Viral load. Her Internal medicine study incorporates themes from Gastroenterology and Diabetes mellitus. Her Cohort research is multidisciplinary, incorporating perspectives in Epidemiology, Incidence, Demography, Confidence interval and Coinfection.
Her Acquired immunodeficiency syndrome research incorporates elements of Hepatitis B, Pathology and Cobra. Her Cohort study study combines topics from a wide range of disciplines, such as Relative risk, Physical therapy, Pediatrics and Immunodeficiency. Her Viral load research is multidisciplinary, incorporating elements of Young adult, Gerontology, Observational study and Surgery.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Combination antiretroviral therapy and the risk of myocardial infarction
Nina Friis-Møller;Caroline A Sabin;Rainer Weber;Antonella d'Arminio Monforte.
The New England Journal of Medicine (2003)
Class of antiretroviral drugs and the risk of myocardial infarction.
Nina Friis-Moller;Peter Reiss;Caroline A. Sabin;Rainer Weber.
The New England Journal of Medicine (2007)
Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.
Matthias Egger;Margaret May;Geneviève Chene;Andrew N. Phillips.
The Lancet (2002)
Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study
Rainer Weber;Caroline A Sabin;Nina Friis-Møller;Peter Reiss.
JAMA Internal Medicine (2006)
Cardiovascular disease risk factors in HIV patients - association with antiretroviral therapy. Results from the DAD study
Nina Friis-Møller;Rainer Weber;Peter Reiss;Rodolphe Thiebaut.
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration
Caroline Sabin;Signe Westring Worm;Rainer Weber.
The Lancet (2008)
Natural history and outcome in systemic AA amyloidosis.
Helen J Lachmann;Hugh J B Goodman;Janet A Gilbertson;J Ruth Gallimore.
The New England Journal of Medicine (2007)
Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration
Colette J Smith;Lene Ryom;Rainer Weber;Philippe Morlat.
The Lancet (2014)
Targeting C-reactive protein for the treatment of cardiovascular disease
Mark B Pepys;Gideon M Hirschfield;Glenys A Tennent;J Ruth Gallimore.
Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study
Signe Westring Worm;Caroline Sabin;Rainer Weber;Peter Reiss.
The Journal of Infectious Diseases (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: